Rituxirel 500 Mg Injection

About Rituxirel 500 Mg Injection

Rituxirel 500 mg Injection is a monoclonal antibodybased anticancer medicine containing Rituximab, widely used in the treatment of certain B-cell malignancies and autoimmune disorders. It works by specifically targeting the CD20 antigen present on B-lymphocytes, leading to destruction of abnormal cells while minimizing damage to healthy tissues.

This injection is commonly prescribed by oncologists and hematologists as part of combination therapy or as a standalone treatment, depending on the patients condition and clinical protocol.

• Generic Name: Rituximab

• Strength: 500 mg

• Dosage Form: Injection

• Non-Hodgkins Lymphoma (NHL)

• Chronic Lymphocytic Leukemia (CLL)

• Rheumatoid Arthritis (in combination with methotrexate)

• Other CD20-positive B-cell disorders (as prescribed)

Rituxirel binds to CD20 antigens on B-cells and induces cell death through immune-mediated mechanisms, helping reduce disease progression and improve treatment outcomes.

• Administered intravenously (IV infusion)

• Dosage and schedule strictly as directed by a qualified healthcare professional

• Given under medical supervision in a hospital or clinical setting

• Store at 2C to 8C

• Do not freeze

• Protect from light

• Prescription medicine; use only under medical supervision

• Not recommended during pregnancy unless clearly needed

• Patients should be monitored for infusion-related reactions